kymriah price
How much is such a treatment worth? For Emily Whiteheadâs parents, Kymriahâs value is priceless. It saved their daughter. But not all share that view. As Kymriah neared FDA approval, many analysts speculated that Novartis would charge anywhere between $600,000 â $750,000. Instead, Novartis set the price at $475,000. Furthermore, Novartis took the stance that payment wouldnât be made unless the patients had responded to Kymriah at the end of the first month after treatment. Nevertheless, critics assailed Novartis for this price.